Bradley B. Pua, M.D.

Vascular and Interventional Radiology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

Interventional Radiology is a rapidly changing field on the forefront of minimally invasive techniques for patient care. One of my main interests include the diagnosis and minimally invasive treatment strategies for lung cancer and its sequela.

It is my belief that the patient-physician relationship does not begin and end with the diagnosis and treatment, but should extend beyond this. At NewYork-Presbyterian Hospital / Weill Cornell Medical Center, our Lung Cancer Screening Program strives to both educate those at high risk for lung cancer and in conjunction with a multidisciplinary group of diagnostic and interventional radiologists, pulmonologists, thoracic surgeons, medical oncologists and radiation oncologists, offer the least invasive treatment approaches.  

Biographical Info

Bradley B. Pua, M.D.

 - Director of the Lung Cancer Screening Program - Chief, Division of Interventional Radiology - Director, Radiology Consultation Services

Dr. Pua obtained a B.S. degree in Chemistry from New York University (NYU) and continued at NYU School of Medicine where he was awarded his M.D. degree. He completed three years of surgical residency at New York University Medical Center prior to deciding to pursue a career in Interventional Radiology and subsequently completed a fellowship in Interventional Radiology at NewYork-Presbyterian Hospital-Weill Cornell Campus & Memorial Sloan Kettering Cancer Center. Dr. Pua remained at Cornell to complete his diagnostic radiology residency and was elected to serve as Chief Resident in his final year.

Dr. Pua's clinical expertise is in Interventional Radiology and performs a variety of interventional procedures including, but not limited to: arterial embolizations, stent placements, tumor ablations, biopsies and vascular access. His interests include both pediatric interventions and minimally invasive cancer therapy, with a particular focus on thoracic tumors.

Dr. Pua's research interests are in simulators for medical education as well as thoracic tumor treatments for which he has written both review articles and book chapters.

Dr. Pua is a reviewer for the Radiology, Journal of Vascular and Interventional Radiology, Clinical Imaging and Journal of Translational Lung Cancer Research.

Board Certifications
American Board of Radiology (Diagnostic Radiology)
American Board of Radiology (Vascular & Interventional Radiology)
Clinical Expertise
Lung Cancer
Tumor Embolization
Pulmonary Arteriovenous Malformation
Radiofrequency Ablation
Thoracic Radiology
Ablation of Lung Lesion
Ablation of Liver Lesion
Vascular Malformation
Bone Cancer
Cancer Pain Management
Lung Biopsy
Lung Cancer-Diagnostic Testing
Low Dose Computed Tomography of Lungs For Lung Cancer Screening
Screening For Lung Cancer
CT Lung Screening
CT Scan of the Chest
  • M.D.
    New York University School of Medicine
  • B.S.
    New York University
  • Associate Attending Radiologist
    NewYork-Presbyterian Hospital
  • Associate Professor of Radiology
    Weill Cornell Medical College, Cornell University
  • Associate Professor of Radiology in Cardiothoracic Surgery
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member: 
GE Healthcare
Proprietary Interest: 
Oxford University Press Inc.
Other Interest: 
Galvanize Therapeutics, Inc.